HIV-1 load quantitation: a 17-year perspective - PubMed (original) (raw)
Review
. 2006 Sep 15:194 Suppl 1:S38-44.
doi: 10.1086/505352.
Affiliations
- PMID: 16921471
- DOI: 10.1086/505352
Review
HIV-1 load quantitation: a 17-year perspective
Mark Holodniy. J Infect Dis. 2006.
Abstract
During the past decade and a half, quantitation of plasma-associated human immunodeficiency virus type 1 (HIV-1) RNA level, or HIV-1 load, has been validated in clinical practice and clinical trials as an important surrogate marker of HIV-1 disease progression and of the potency and durability of antiretroviral regimens. This review highlights some of the history, accomplishments, and impact of Tom Merigan's laboratory on the use of HIV-1 load as a marker, as well as on updating technologies for determining HIV-1 load, their performance, interpretation of the results, and their use in clinical practice.
Similar articles
- Evaluation of the NucliSens EasyQ HIV-1 v1.1 and RealTime HIV-1 kits for quantitation of HIV-1 RNA in plasma.
Choi JY, Kim EJ, Rho HJ, Kim JY, Kwon OK, Lee JH, Koo MJ, Kim SS. Choi JY, et al. J Virol Methods. 2009 Oct;161(1):7-11. doi: 10.1016/j.jviromet.2009.02.003. Epub 2009 Feb 12. J Virol Methods. 2009. PMID: 19576640 - Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource-limited settings?
Bagchi S, Kempf MC, Westfall AO, Maherya A, Willig J, Saag MS. Bagchi S, et al. Clin Infect Dis. 2007 Jan 1;44(1):135-8. doi: 10.1086/510072. Epub 2006 Nov 28. Clin Infect Dis. 2007. PMID: 17143829 - HIV viral load: the myth of the undetectable?
Pillay D. Pillay D. Rev Med Virol. 2002 Nov-Dec;12(6):391-6. doi: 10.1002/rmv.373. Rev Med Virol. 2002. PMID: 12410530 Review. - The measurement of HIV-1 viral load in resource-limited settings: how and where?
Rouet F, Rouzioux C. Rouet F, et al. Clin Lab. 2007;53(3-4):135-48. Clin Lab. 2007. PMID: 17447649 Review. - Viral load in peripheral blood mononuclear cells as surrogate for clinical progression.
Ferre F, Moss RB, Daigle A, Richieri SP, Jensen F, Carlo DJ. Ferre F, et al. J Acquir Immune Defic Syndr Hum Retrovirol. 1995;10 Suppl 2:S51-6. J Acquir Immune Defic Syndr Hum Retrovirol. 1995. PMID: 7552513 Review.
Cited by
- The transient effect of a peer support intervention to improve adherence among adolescents and young adults failing antiretroviral therapy in Harare, Zimbabwe: a randomized control trial.
Ndhlovu CE, Kouamou V, Nyamayaro P, Dougherty L, Willis N, Ojikutu BO, Makadzange AT. Ndhlovu CE, et al. AIDS Res Ther. 2021 Jun 16;18(1):32. doi: 10.1186/s12981-021-00356-w. AIDS Res Ther. 2021. PMID: 34134738 Free PMC article. Clinical Trial. - Evaluation of effect of specimen-handling parameters for plasma preparation tubes on viral load measurements obtained by using the Abbott RealTime HIV-1 load assay.
Fernandes H, Morosyuk S, Abravaya K, Ramanathan M, Rainen L. Fernandes H, et al. J Clin Microbiol. 2010 Jul;48(7):2464-8. doi: 10.1128/JCM.00083-10. Epub 2010 May 19. J Clin Microbiol. 2010. PMID: 20484602 Free PMC article. - High systemic levels of interleukin-10, interleukin-22 and C-reactive protein in Indian patients are associated with low in vitro replication of HIV-1 subtype C viruses.
Arias JF, Nishihara R, Bala M, Ikuta K. Arias JF, et al. Retrovirology. 2010 Mar 9;7:15. doi: 10.1186/1742-4690-7-15. Retrovirology. 2010. PMID: 20211031 Free PMC article. - Defining treatment failure in resource-rich settings.
Aldous JL, Haubrich RH. Aldous JL, et al. Curr Opin HIV AIDS. 2009 Nov;4(6):459-66. doi: 10.1097/COH.0b013e328331dea5. Curr Opin HIV AIDS. 2009. PMID: 20048711 Free PMC article. Review. - The economics of treating chronic hepatitis B in Asia.
Dan YY, Aung MO, Lim SG. Dan YY, et al. Hepatol Int. 2008 Sep;2(3):284-95. doi: 10.1007/s12072-008-9049-2. Epub 2008 May 1. Hepatol Int. 2008. PMID: 19669256 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous